Skip to main content

LCD L39490: Ambulatory Electrocardiograph (AECG) Monitoring

LCD L39490, Ambulatory Electrocardiograph (AECG) Monitoring, is the Local Coverage Determination that Novitas Solutions, Inc. applies to claims from 11 states plus DC (AR, CO, DC, DE, LA, MD, MS, NJ and others), effective 2023-06-11. The policy text runs 835 words, and its billing and coding article A59268 lists 158 ICD-10-CM codes that support medical necessity for 23 procedure codes. 1 other contractor version share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 158 covered ICD-10-CM codes: the same total as L39492 (First Coast Service Options, Inc., 158 codes, revised 2023-06-11).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Novitas Solutions, Inc.
States and territories
12
AR CO DC DE LA MD MS NJ NM OK PA TX
Revision effective
2023-06-11
Original effective
2023-06-11
Policy text
835 words
Covered ICD-10 codes (articles)
158

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L39490
ContractContractorTypeStates
12101Novitas Solutions, Inc.A and B MACDE
12201Novitas Solutions, Inc.A and B MACDC
12301Novitas Solutions, Inc.A and B MACMD
12401Novitas Solutions, Inc.A and B MACNJ
12501Novitas Solutions, Inc.A and B MACPA
12102Novitas Solutions, Inc.A and B MACDE
12202Novitas Solutions, Inc.A and B MACDC
12302Novitas Solutions, Inc.A and B MACMD
12402Novitas Solutions, Inc.A and B MACNJ
12502Novitas Solutions, Inc.A and B MACPA
12901Novitas Solutions, Inc.A and B MACDC DE MD NJ PA
07102Novitas Solutions, Inc.A and B MACAR
07202Novitas Solutions, Inc.A and B MACLA
07101Novitas Solutions, Inc.A and B MACAR
07201Novitas Solutions, Inc.A and B MACLA
07301Novitas Solutions, Inc.A and B MACMS
07302Novitas Solutions, Inc.A and B MACMS
04111Novitas Solutions, Inc.A and B MACCO
04211Novitas Solutions, Inc.A and B MACNM
04311Novitas Solutions, Inc.A and B MACOK
04411Novitas Solutions, Inc.A and B MACTX
04112Novitas Solutions, Inc.A and B MACCO
04212Novitas Solutions, Inc.A and B MACNM
04312Novitas Solutions, Inc.A and B MACOK
04412Novitas Solutions, Inc.A and B MACTX
04911Novitas Solutions, Inc.A and B MACCO NM OK TX

Billing and coding article A59268: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A59268 (Billing and Coding: Ambulatory Electrocardiograph (AECG) Monitoring) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A59268: Billing and Coding: Ambulatory Electrocardiograph (AECG) Monitoring (Billing and Coding, effective 2026-10-01)

Covered ICD-10-CM codes
158
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
23
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A59268
ICD-10-CMDescription (FY2027)
G45.3Amaurosis fugax
G45.8Other transient cerebral ischemic attacks and related syndromes
G45.9Transient cerebral ischemic attack, unspecified
G90.01Carotid sinus syncope
I20.0Unstable angina
I20.1Angina pectoris with documented spasm
I20.81Angina pectoris with coronary microvascular dysfunction
I20.89Other forms of angina pectoris
I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
I21.21ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
I21.29ST elevation (STEMI) myocardial infarction involving other sites
I21.4Non-ST elevation (NSTEMI) myocardial infarction
I21.A1Myocardial infarction type 2
I21.A9Other myocardial infarction type
I21.BMyocardial infarction with coronary microvascular dysfunction
I22.0Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
I22.1Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
I22.8Subsequent ST elevation (STEMI) myocardial infarction of other sites
I23.7Postinfarction angina

Procedure codes: 0937T, 0938T, 0939T, 0940T, 93224, 93225, 93226, 93227, 93228, 93229, 93241, 93242, 93243, 93244, 93245, 93246, 93247, 93248, 93268, 93270, 93271, 93272, 93298.

Coverage indications, limitations and medical necessity

Compliance with the provisions in this LCD may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Ambulatory Electrocardiograph (AECG) diagnostic procedures provide a record of the heart rhythm during daily activities. AECG can often identify the existence and determine the frequency of clinically significant rhythm disturbances and waveform abnormalities that are missed on a standard electrocardiogram (ECG).

AECG continues to advance at a rapid pace and incorporates various monitoring devices and indications for use. These devices range from Holter Monitors, Event Recorders/Monitors, Patch Recorders, External Loop Recorders, Mobile Cardiovascular Telemetry, Mobile Cardiovascular Outpatient Telemetry, Insertable Cardiac Monitor/Internal Loop Recorders, and Subcutaneous Cardiac Rhythm Monitors. They are differentiated by capabilities and the varying technical components among devices, such as intermittent/continuous recording, patient/rhythm activated recording, number of leads, time frames of use and whether the rhythm is interpreted in real time (attended surveillance) or if it is transferred from the device and interpreted at a later time. Regardless of the equipment, these devices provide valuable data for diagnosis of palpitations, syncope and other signs and symptoms suggestive of cardiac arrhythmia.

The scope of this LCD is to define the specific patient indications that support medical necessity for this type of monitoring.

Definitions

Acute Coronary Syndrome (ACS) – applies to patients with suspicion or confirmation of acute myocardial ischemia or infarction. It describes a large array of signs and symptoms that range from atypical chest discomfort, nonspecific electrocardiographic changes, normal cardiac biomarkers, non-ST-elevation myocardial infarction (NSTEMI), large ST-segment elevation myocardial infarction (STEMI), and cardiogenic shock. 1

Silent Myocardial Ischemia – is defined as ‘objective documentation of myocardial ischemia in the absence of angina or anginal equivalents.’ 2

24-hour Monitoring Station (applicable only to mobile cardiac telemetry) - is defined as a facility in operation 24-hours per day, seven days a week, with a receiving station staffed with EKG technicians or other non-physician staff on a 24-hour per day basis. The technicians should have immediate 24-hour access to a physician to review transmitted data that falls outside of set parameters. The technicians should know how to contact available facilities to assist in any cardiac emergencies. 3,4,5 .

Covered Indications

AECG monitoring, when performed with a device that has FDA clearance, will be considered medically reasonable and necessary in the following situations:

• A standard 12-lead electrocardiograph (ECG), complete cardiac history and cardiac exam has not satisfactorily explained the patient's cardiac complaints and AECG testing will provide diagnostic information that will assist in developing a treatment plan or changing a treatment plan for patients that are at risk for cardiac arrythmias. 3,6,7

OR

• For patients experiencing unexplained syncope, near syncope, episodic dizziness, chest pain, palpitations, and/or shortness of breath. 6

OR

• To assess documented or suspected bradycardia. 8

OR

• For patients experiencing nocturnal arrhythmias. 6

OR

• To assess the average heart rate and adequacy of rate control in a patient with atrial fibrillation. 6

OR

• To aid in the regulation of anti-arrhythmic drug dosage. 3,6,7,9

OR

• To assess the effectiveness of arrhythmia therapy (e.g., post ablation). 6

OR

• To evaluate prognosis following acute coronary syndrome. 6,10

OR

• Pre/Post implantable cardiac defibrillator reprogramming. 7

OR

• To assess for silent myocardial ischemia in a patient with known or suspected coronary heart disease. 3,6

OR

• To assess for asymptomatic ventricular premature beats or non-sustained ventricular tachycardia in patients with hypertrophic (descriptor licensed by AMA), long QT syndrome, dilated or restrictive cardiomyopathy, congenital heart disease, or Brugada syndrome. 6,7

OR

• To evaluate for occult atrial fibrillation (A-Fib) as a potential cause of cardio-embolism in patients with cryptogenic stroke. 4,6

Note: A 24-48 hour monitor is most appropriate for patients with daily or near daily symptoms. 6 Otherwise, providers should order the most appropriate type of AECG for the patient based on their evaluation of the patient, the patient’s symptoms and the devices’ labeled indications.

Note: The duration of monitoring should be consistent with the patient’s signs and symptoms. 3,6,11,12,13

Limitations

The following are considered not medically reasonable and necessary:

• Devices that do not have FDA clearance, including non-physician prescribed; hand/wrist held – smart phone based devices.

• AECG monitoring of potentially harmful ventricular arrhythmias requiring inpatient level of care. 12,14

• Any 24-hour monitoring station that does not meet the definition in the definition section. 3,4,5

Please refer to NCD 20.15 for additional indications and limitations.

Provider Qualifications

Services will be considered medically reasonable and necessary when all aspects of care are within the scope of practice of the provider’s professional licensure, when performed according to the supervision requirements per state scope of practice laws, and when all procedures are performed by appropriately trained providers in the appropriate setting.

Notice: Services performed for any given diagnosis must meet the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

Summary of evidence (opening)

Clinical Practice

Zimetbaum et al 14 provides an overview and evaluation for care with patients that present with palpitations. There are many factors to be considered in the etiology of palpitations. Cardiac disorders are the most common cause of palpitations and include arrhythmias, structural heart disease, conduction system abnormalities, valvular disease, pacemaker syndrome, atrial myoma, sympathetic stimulation and catecholamine release during exercise and high output cardiac states. Other etiology of palpitations may include psychiatric disorders, medication effects, substance abuse, endocrine disorders, and metabolic disorders.

The workup for a patient who presents with palpitations typically includes an extensive medical history along with a 12-lead ECG, physical exam and limited laboratory testing. 14(p3)

When an arrhythmia is not identified on the 12-lead ECG, the patient’s medical history can be helpful to note the age of symptom onset, duration of palpitations, heart rate and rhythm regularity, additional symptoms that are associated with the palpitations (pre-syncope or syncope), the onset and resolution of the palpitations, effects of positional changes and if the patient is able to alleviate the palpitations on their own. In addition, the cardiac exam should include the patient’s family cardiac history and co-existing medical conditions such as pregnancy, metabolic and endocrine issues, chronic obstructive pulmonary disease, and psychiatric disorders. 14(p2)

The contractor cites 32 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2023-06-11
Current revision effective
2023-06-11
MCD version
7

The contractor lists one National Coverage Determination as related: NCD 20.15 Electrocardiographic Services. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Other related documents: A59366 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Novitas Solutions, Inc. hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L39490 cover?

Ambulatory Electrocardiograph (AECG) diagnostic procedures provide a record of the heart rhythm during daily activities. AECG can often identify the existence and determine the frequency of clinically significant rhythm disturbances and waveform abnormalities that are missed on a standard electrocardiogram (ECG). The full 835-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L39490 apply to?

Novitas Solutions, Inc. applies it to Medicare claims in 11 states plus DC: AR, CO, DC, DE, LA, MD, MS, NJ, NM, OK, PA, TX. It binds only that contractor; 1 other contractor version of this title governs other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L39490?

The companion billing and coding article A59268 lists 158 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L39490?

A denial under LCD L39490 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A59268's 158 covered diagnosis codes, then file a redetermination with Novitas Solutions, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.